Lundbeck wins patent case against six generic medicine producers
A legal dispute over the patent rights for depression treatment Trintellix has been resolved in favor of Lundbeck and its partner Takeda, as a US judge has ruled to uphold patent protection on the drug's active ingredient.
by elizabeth mønsted johansen, translated by catherine brett
Lundbeck has managed to stave off generic medicine producers – for now. The company and its partner, Takeda, have won a legal battle in the US.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.